Sort
17,054 grants matching “genome editing”
Hematologic Malignancies
$32,606Thomas J. Kipps · University Of California, San Diego · P30 · FY2023 · CA
Hematologic Malignancies
$32,589Thomas J. Kipps · University Of California, San Diego · P30 · FY2021 · CA
Molecular imaging meets big data: a systems-level approach for application-driven, unbiased selection of metabolic imaging substrates for visualization of cancer dormancy
$32,585Nicholas Rainer Perkons · University Of Pennsylvania · F30 · FY2020 · CA
Trinucleotide repeat disorders and the 3D genome
$32,585Linda Zhou · University Of Pennsylvania · F30 · FY2020 · HD
Elucidating the mechanisms of CDK inhibitor resistance in cancer using chemical proteomics
$32,520Esther Kim Kemper · Scripps Research Institute, The · F31 · FY2020 · CA
Hematologic Malignancies
$32,486Thomas J. Kipps · University Of California, San Diego · P30 · FY2019 · CA
Establishing and Optimizing a Prime Editing Method in Neurons for Treatment of Rett Syndrome
$32,460David G. Keener · Univ Of Massachusetts Med Sch Worcester · F31 · FY2023 · NS
Systematic mapping and prediction of gene-enhancer connections
$32,400Jesse M Engreitz · Broad Institute, Inc. · K99 · FY2019 · HG
Characterizing HBEGF in glioma formation and maintenance
$32,385Clifford Shin · University Of Utah · F30 · FY2018 · CA
Amelioration of Beta-hemoglobinopathies by efficient precise deletion of the +58 BCL11A enhancer using orthogonal Cas9-Cas9 chimeras
$32,329Kevin Luk · Univ Of Massachusetts Med Sch Worcester · F31 · FY2019 · HL
Elucidating the mechanism of anti-GSK3 adjuvant therapy for Myc-driven lymphomas
$32,083Colleen T Harrington · University Of Pennsylvania · F31 · FY2019 · CA
Molecular imaging meets big data: a systems-level approach for application-driven, unbiased selection of metabolic imaging substrates for visualization of cancer dormancy
$32,081Nicholas Rainer Perkons · University Of Pennsylvania · F30 · FY2019 · CA
Genome Engineered Natural Killer Cell Immunotherapy against Human Osteosarcoma
$32,017Gabrielle Matilde Robbins · University Of Minnesota · F30 · FY2021 · OD
Elucidating the mechanisms of CDK inhibitor resistance in cancer using chemical proteomics
$32,016Esther Kim Kemper · Scripps Research Institute, The · F31 · FY2019 · CA
Identification of Essential Factors for the Alternative Lengthening of Telomeres Pathway
$32,016Taylor Kristine Loe · Scripps Research Institute, The · F31 · FY2019 · CA
Aberrant Splicing in the Cardiac Arrhythmias
$32,007Matthew O'Neill · Vanderbilt University · F30 · FY2022 · HL
The APOBEC in APOBEC mutagenesis
$31,973Matthew C Jarvis · University Of Minnesota · F31 · FY2021 · CA
Roles of E2F3 and SGO1 in the Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
$31,880Shirley Jusino-Cotto · Ponce School Of Medicine · F31 · FY2019 · CA
Investigating the role of the Unfolded Protein Response in Genetic Dilated Cardiomyopathy
$31,808Rachel Baum · Stanford University · F32 · FY2025 · HL
Blood Cell Development and Function Program (02)
$31,780Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · P30 · FY2016 · CA
Investigating the Roles of ADARs and A-to-I RNA Editing in Germline RNA Regulation
$31,724Emily Ann Erdmann · Trustees Of Indiana University · F31 · FY2023 · HD
EGFR T790M-mediated drug resistance in non-small cell lung cancer
$31,649Pinar Ozden Eser · Harvard Medical School · F31 · FY2017 · CA
Hypoxia-induced mutagenesis and resistance to targeted therapy
$31,644Marco Maruggi · Sanford Burnham Prebys Medical Discovery Institute · F31 · FY2017 · CA
Investigating the Epigenetic Regulation of Imprinted Gene Grb10 in Neurodevelopment
$31,614Aimee Juan · University Of Pennsylvania · F31 · FY2018 · HD
A novel class of long non-coding RNA in regulation of the type I interferonresponse
$31,607Annsea Park · Yale University · F30 · FY2022 · AI